JP2019514977A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514977A5 JP2019514977A5 JP2018558279A JP2018558279A JP2019514977A5 JP 2019514977 A5 JP2019514977 A5 JP 2019514977A5 JP 2018558279 A JP2018558279 A JP 2018558279A JP 2018558279 A JP2018558279 A JP 2018558279A JP 2019514977 A5 JP2019514977 A5 JP 2019514977A5
- Authority
- JP
- Japan
- Prior art keywords
- valerian
- dosage form
- pharmaceutical dosage
- pharmaceutical
- polymer matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013832 Valeriana officinalis Nutrition 0.000 claims description 43
- 244000126014 Valeriana officinalis Species 0.000 claims description 43
- 235000016788 valerian Nutrition 0.000 claims description 43
- 239000002535 acidifier Substances 0.000 claims description 19
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 7
- 229940095602 acidifiers Drugs 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims 41
- 229920000642 polymer Polymers 0.000 claims 28
- 239000000203 mixture Substances 0.000 claims 19
- 239000011159 matrix material Substances 0.000 claims 17
- 238000013268 sustained release Methods 0.000 claims 11
- 239000012730 sustained-release form Substances 0.000 claims 11
- 238000004519 manufacturing process Methods 0.000 claims 6
- 239000007787 solid Substances 0.000 claims 5
- 239000002775 capsule Substances 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 4
- 239000008363 phosphate buffer Substances 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 238000010521 absorption reaction Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000017164 Chronobiology disease Diseases 0.000 claims 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 206010022437 insomnia Diseases 0.000 claims 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 claims 1
- 229960003987 melatonin Drugs 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 238000006114 decarboxylation reaction Methods 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022089010A JP7577090B2 (ja) | 2016-05-06 | 2022-05-31 | バレリアン組成物及び関連方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662332728P | 2016-05-06 | 2016-05-06 | |
| US62/332,728 | 2016-05-06 | ||
| PCT/US2017/031046 WO2017192843A1 (en) | 2016-05-06 | 2017-05-04 | Valerian composition and related methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022089010A Division JP7577090B2 (ja) | 2016-05-06 | 2022-05-31 | バレリアン組成物及び関連方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514977A JP2019514977A (ja) | 2019-06-06 |
| JP2019514977A5 true JP2019514977A5 (enExample) | 2022-01-06 |
| JP7576905B2 JP7576905B2 (ja) | 2024-11-01 |
Family
ID=60203773
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558279A Active JP7576905B2 (ja) | 2016-05-06 | 2017-05-04 | バレリアン組成物及び関連方法 |
| JP2022089010A Active JP7577090B2 (ja) | 2016-05-06 | 2022-05-31 | バレリアン組成物及び関連方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022089010A Active JP7577090B2 (ja) | 2016-05-06 | 2022-05-31 | バレリアン組成物及び関連方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10342873B2 (enExample) |
| EP (1) | EP3452020A4 (enExample) |
| JP (2) | JP7576905B2 (enExample) |
| KR (1) | KR20190008265A (enExample) |
| CN (2) | CN117482062A (enExample) |
| AU (1) | AU2017260019A1 (enExample) |
| CA (1) | CA3023305C (enExample) |
| MX (1) | MX2018013569A (enExample) |
| RU (1) | RU2018142019A (enExample) |
| WO (1) | WO2017192843A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4090315A1 (en) * | 2020-01-17 | 2022-11-23 | Société des Produits Nestlé S.A. | Dosage form with sustained release melatonin pellets |
| IT202200013576A1 (it) * | 2022-06-27 | 2023-12-27 | S I I T S R L Servizio Int Imballaggi Termosaldanti | Compressa multistrato a rilascio differenziato di melatonina e principi attivi |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2699075A1 (fr) | 1992-12-11 | 1994-06-17 | Rech Sarl Ab | Préparation médicinale à libération programmable dans le temps notamment à base de plantes. |
| FR2713636B1 (fr) | 1993-12-07 | 1996-01-05 | Adir | Nouveaux dérivés naphtaléniques, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent. |
| FR2727315A1 (fr) | 1994-11-30 | 1996-05-31 | Cooperative Agricole Laitiere | Utilisation d'un decapeptide a activite de type benzodiazepine pour la preparation de medicaments et de complements alimentaires |
| US5840332A (en) | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
| US6034239A (en) | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
| KR100499106B1 (ko) | 1996-12-10 | 2005-07-01 | 브리스톨-마이어즈 스퀴브 컴페니 | 벤조디옥솔, 벤조퓨란, 디히드로벤조퓨란, 및 벤조디옥산 멜라토닌 작용제 |
| CA2379395A1 (en) | 1999-07-21 | 2001-02-01 | Ancile Pharmaceuticals, Inc. | Process for the extraction of valerian root |
| US6419956B1 (en) * | 1999-12-30 | 2002-07-16 | Ancile Pharmaceuticals | Odor-masking coating for a pharmaceutical preparation |
| US20050129783A1 (en) | 2001-04-19 | 2005-06-16 | Mccleary Edward L. | Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health |
| JP4532903B2 (ja) | 2001-12-20 | 2010-08-25 | アルペックス ファーマ ソシエテ アノニム | 微粒子組成物 |
| JP4951162B2 (ja) * | 2004-04-06 | 2012-06-13 | 太陽化学株式会社 | 睡眠改善用組成物 |
| US8383154B2 (en) | 2004-05-11 | 2013-02-26 | Egalet A/S | Swellable dosage form comprising gellan gum |
| CA2583794C (en) | 2004-10-11 | 2015-05-26 | Nasaleze Ppm Limited | Compositions for intranasal administration |
| ZA200711048B (en) | 2005-06-22 | 2009-05-27 | Takeda Pharmaceutical | Tablet containing hardly soluble active incredient |
| WO2007095716A1 (en) * | 2006-02-23 | 2007-08-30 | Iomedix Sleep International Srl | Compositions and methods for the induction and maintenance of quality sleep |
| CN1850212A (zh) * | 2006-02-28 | 2006-10-25 | 潮州市强基制药厂 | 一种缬草油液体硬胶囊及其制备方法 |
| ES2452342T3 (es) | 2006-09-27 | 2014-04-01 | Finzelberg Gmbh & Co. Kg | Preparación de extracto de valeriana |
| US20080248106A1 (en) | 2007-04-05 | 2008-10-09 | Marvin Heuer | Melatonin-based composition for improved sleep |
| US20090197974A1 (en) * | 2008-02-05 | 2009-08-06 | Khaleeq Ahmed | Natural dietary supplement tablet |
| EP2389350A1 (en) | 2009-01-23 | 2011-11-30 | Valericon GmbH | Methods for making valerenic acid derivatives and their use |
| US20110064712A1 (en) | 2009-09-16 | 2011-03-17 | Daniel Moses Amato | Dietary Supplement Compositions and Methods of Making and Using the Same |
| CN102370833B (zh) * | 2010-08-17 | 2014-03-26 | 北京亚东生物制药有限公司 | 一种解表祛暑的泡腾剂及其制备方法和用途 |
| CN102058630B (zh) * | 2010-12-16 | 2014-03-19 | 苏州大学 | 一种镇静安神的缬草制剂及其制备方法 |
| CN102247443A (zh) | 2010-12-23 | 2011-11-23 | 祝凤仪 | 治疗神经衰弱中药外洗粉、泡腾片的配方及其制备方法 |
| JP5600747B2 (ja) | 2011-01-17 | 2014-10-01 | 武田薬品工業株式会社 | 口腔内分散性製剤 |
| US8691275B2 (en) | 2011-01-28 | 2014-04-08 | Zx Pharma, Llc | Controlled-release melatonin compositions and related methods |
| CN102114060B (zh) * | 2011-02-22 | 2012-12-12 | 都晓伟 | 黑水缬草提取物及其制备方法和应用 |
| JP2013053144A (ja) * | 2011-08-09 | 2013-03-21 | Daiichi Sankyo Healthcare Co Ltd | 鎮静剤組成物 |
| WO2013061161A2 (en) * | 2011-10-28 | 2013-05-02 | Green Bcn Consulting Services Sl | New combination therapies for treating neurological disorders |
| IL330095A (en) | 2012-01-26 | 2026-08-01 | Vanda Pharmaceuticals Inc | Tesimalta for use in the treatment of asynchronous circadian rhythm of cortisol |
| JP2015509708A (ja) | 2012-01-26 | 2015-04-02 | ウィキフーズ，インコーポレイテッド | 材料の天然輸送系内への封入 |
| CA2928777A1 (en) | 2012-11-09 | 2014-06-05 | Abattis Bioceuticals Corp. | Nitric oxide increasing nutritional supplements and methods |
| US20140271890A1 (en) | 2013-03-14 | 2014-09-18 | Thaer Ahmad | Controlled-release pharmaceutical composition |
| BR112015006499A2 (pt) | 2013-04-23 | 2017-07-04 | Zx Pharma Llc | composição de óleo de horlelã-pimenta de liberação controlada microparticulada com revestimento entérico e métodos relacionados |
| PL231923B1 (pl) | 2013-10-28 | 2019-04-30 | Proteon Pharmaceuticals Spolka Akcyjna | Sposób enkapsulacji materiału zawierającego bakteriofagi, otrzymywana nim mikrokapsułka oraz jej zastosowania |
| RU2535020C1 (ru) | 2014-01-23 | 2014-12-10 | Карпов Алексей Николаевич | Фармацевтическая композиция седативного и спазмолитического действия |
| MY177906A (en) * | 2014-02-06 | 2020-09-25 | Sequential Medicine Ltd | Composition and method for aiding sleep |
| ES2706302T3 (es) * | 2014-05-05 | 2019-03-28 | Sanofi Aventis Deutschland | Granulado de disolución rápida |
| PT2974733T (pt) | 2014-07-14 | 2016-10-24 | Dr Willmar Schwabe Gmbh & Co Kg | Combinação de extracto de raiz de valeriana e óleo de alfazema para tratamento de distúrbios de sono |
-
2017
- 2017-05-04 JP JP2018558279A patent/JP7576905B2/ja active Active
- 2017-05-04 CA CA3023305A patent/CA3023305C/en active Active
- 2017-05-04 AU AU2017260019A patent/AU2017260019A1/en not_active Abandoned
- 2017-05-04 EP EP17793336.3A patent/EP3452020A4/en active Pending
- 2017-05-04 US US15/586,709 patent/US10342873B2/en active Active
- 2017-05-04 MX MX2018013569A patent/MX2018013569A/es unknown
- 2017-05-04 CN CN202311459688.5A patent/CN117482062A/zh active Pending
- 2017-05-04 KR KR1020187035039A patent/KR20190008265A/ko not_active Ceased
- 2017-05-04 RU RU2018142019A patent/RU2018142019A/ru not_active Application Discontinuation
- 2017-05-04 CN CN201780027996.7A patent/CN109310638A/zh active Pending
- 2017-05-04 WO PCT/US2017/031046 patent/WO2017192843A1/en not_active Ceased
-
2019
- 2019-07-03 US US16/502,976 patent/US11141484B2/en active Active
- 2019-07-09 US US16/506,443 patent/US11141485B2/en active Active
-
2021
- 2021-09-08 US US17/469,458 patent/US11701425B2/en active Active
-
2022
- 2022-05-31 JP JP2022089010A patent/JP7577090B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200635618A (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
| JP2016540021A5 (enExample) | ||
| NZ590291A (en) | Pharmaceutical compositions for treatment of parkinson's disease | |
| MX2015011896A (es) | Formulacion de liberacion sostenida de mosapride que proporciona efectos farmacologicos y clinicos con administracion una vez al dia. | |
| JP2007530543A5 (enExample) | ||
| RU2015143515A (ru) | Твердые таблетки и капсулы модифицированного высвобождения бензонатата | |
| JP2015523407A5 (enExample) | ||
| RU2014126879A (ru) | Композиции акампросата, способы их применения и содержащие их комбинации | |
| JP2024507991A (ja) | 激越を処置するための方法及び組成物 | |
| NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
| AR056824A1 (es) | Tableta de neramexano con matriz de liberacion modificada | |
| MX2019015733A (es) | Formulacion de melatonina oralmente disoluble con agente acidificante que produce melatonina soluble en saliva. | |
| JP2016530291A5 (enExample) | ||
| ES2733649T3 (es) | Formulación farmacéutica de liberación lenta | |
| JP2009507048A5 (enExample) | ||
| JP2020511419A5 (enExample) | ||
| JP2016503803A5 (enExample) | ||
| JP5403935B2 (ja) | 経口用の慢性疼痛予防または治療剤 | |
| JP2015120758A5 (enExample) | ||
| JP2022116251A5 (enExample) | ||
| ES2985625T3 (es) | Formas de dosificación sólidas de vigabatrina | |
| JP2014513130A5 (enExample) | ||
| CA2648538A1 (en) | Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles | |
| JP2009508916A5 (enExample) | ||
| RU2006143659A (ru) | Применение ребоксетина для лечения боли |